Huang X, Lin S, Rao X, Zeng D, et al. First-line Treatment with Ribociclib plus Endocrine Therapy for Premenopausal Women with Hormone-receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis. Clin Breast Cancer 2021 Feb 4. pii: S1526-8209(21)00041.
PMID: 33676870